Results 111 to 120 of about 17,227 (165)

Proliferation and apoptosis of prostatic cancer cell lines under the influence of Topotecan, Etoposid, Estramustinphosphat and Docetaxel

, 2011
Die vorliegende Arbeit untersucht die Effekte der Zytostatika Topotecan, Etoposid, Docetaxel und Estramustinphopat auf die Hemmung der Zellproliferation und die Induktion von Apoptose bei den Prostatakarzinomzelllinien LNCaP, DU-145 und PC-3.
Adam, Meike
core  

Decoding Small Cell Lung Cancer: Molecular Subtypes, Surface Antigens, and the Target-Modality Problem. [PDF]

Cancers (Basel)
Zambrano Iglesias MI, Rosas D, Akgun S, Padron Cubillan IC, Richani Meinhardt FW, Hussein A, Raez LE.   +6 more
europepmc   +1 more source

The Influence of TDP1 Inhibitor Usnic Acid Derivative OL9-116 on the Effects of Topotecan in Human Cells. [PDF]

Curr Issues Mol Biol
Kornienko TE, Chepanova AA, Kolobenko MV, Chernyshova IA, Zakharenko AL, Venzel AS, Dyrkheeva NS, Markov AV, Anarbaev RO, Naumenko KN, Luzina OA, Salakhutdinov NF, Ivanisenko VA, Lavrik OI.   +13 more
europepmc   +1 more source

Treatment of leukemic ocular infiltrations with intraarterial chemotherapy in very early mixed relapse of B-cell acute lymphoblastic leukemia. [PDF]

Haematologica
Andrzejewska M, Deręgowski M, Anioł Z, Dezor-Garus J, Stodolska A, Rutkowska S, Przybyłowicz-Chalecka A, Zając-Spychała O, Gotz-Więckowska A, Derwich K.   +9 more
europepmc   +1 more source

Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis. [PDF]

Ann Med
Ying T, E S, Ying H.
europepmc   +1 more source

TLR4 and RB1 as the Identified Lactate-Related Genes to Predict the Diagnostic Performance, Gene Regulatory Network, and Targeting Drugs in Depression. [PDF]

Hum Mutat
Ding F, Chen J, Wu J, Bian Q.
europepmc   +1 more source

Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies. [PDF]

Mol Med
Reddy Y, Pai P, Das I, Nayak S, D'Souza NV, Shetty MG, Sundara BK.   +6 more
europepmc   +1 more source

Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers. [PDF]

Mol Carcinog
Bai J, Ji F, Zhao X, Wang H, Huang X, Wei J, Yang Z, Chen S, Zhang W, Zhang P, He X, Liu L, Xu G.   +12 more
europepmc   +1 more source

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250). [PDF]

ESMO Open
Navarro A, Thomas A, Cheng Y, Chen Y, Reguart N, Yoshida T, Cousin S, Dong X, Yamamoto N, Cappuzzo F, Hallwachs R, Bolleddula J, Sarholz B, Grombacher T, Otte M, Gounaris I, Ferrer J, Moulin C, Paz-Ares L.   +18 more
europepmc   +1 more source

Role of additional topotecan injections (plus two) in reducing recurrence rate in retinoblastoma of group D and group E patients: a retrospective study. [PDF]

BMJ Open Ophthalmol
Lin X, Zheng Z, Chen H, Qian J, Liu Q, Ma R, Xue K.   +6 more
europepmc   +1 more source